Ingmar Hoerr
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- RNA and protein synthesis mechanisms
- vaccines and immunoinformatics approaches
Papers in
- Immunology 14
- Immunotherapy and Immune Responses 13
-
- RNA Interference and Gene Delivery 4
- DNA and Nucleic Acid Chemistry 1
- Co-authors
- Hans‐Georg Rammensee (13 shared papers)Steve Pascolo (11 shared papers)Birgit Scheel (11 shared papers)Günther Jung (5 shared papers)Jochen Probst (8 shared papers)Benjamin Weide (4 shared papers)Reinhard Obst (2 shared papers)Claus Garbe (3 shared papers)
- Journals
- European Journal of Immunology (4 papers)Journal for ImmunoTherapy of Cancer (2 papers)OncoImmunology (2 papers)Journal of Immunotherapy (2 papers)Cellular and Molecular Life Sciences (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Ingmar Hoerr
20 papers receiving 2.5k citations
Ingmar Hoerr's Hit Papers
Peers
Comparison fields: 5 of 71
- Immunology 1.2k
- Molecular Biology 1.3k
- Infectious Diseases 387
- Virology 66
- Oncology 197
Countries citing papers authored by Ingmar Hoerr
This map shows the geographic impact of Ingmar Hoerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Hoerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Hoerr more than expected).
Fields of papers citing papers by Ingmar Hoerr
This network shows the impact of papers produced by Ingmar Hoerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Hoerr. The network helps show where Ingmar Hoerr may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingmar Hoerr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial Hit paper breakdown → | 2017 | 435 |
| 2 | 2009 | 330 | |
| 3 | 2000 | 318 | |
| 4 | 2015 | 240 | |
| 5 | 2008 | 225 | |
| 6 | 2010 | 193 | |
| 7 | 2007 | 181 | |
| 8 | 2005 | 178 | |
| 9 | 2019 | 167 | |
| 10 | 2004 | 126 | |
| 11 | 2006 | 97 | |
| 12 | 2006 | 69 | |
| 13 | 2015 | 52 | |
| 14 | 2005 | 30 | |
| 15 | 2005 | 21 | |
| 16 | 2016 | 20 | |
| 17 | 2016 | 11 | |
| 18 | 2000 | 8 | |
| 19 | 2021 | 6 | |
| 20 | 2017 | 3 |
About Ingmar Hoerr
Ingmar Hoerr is a scholar working on Immunology, Molecular Biology, Virology, Oncology and Management of Technology and Innovation, having authored 20 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), RNA Interference and Gene Delivery (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Rabies epidemiology and control (1 paper), Biotechnology and Related Fields (1 paper), History of Science and Medicine (1 paper), Pharmaceutical Economics and Policy (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). The work is most often cited by research in Immunology (1.2k citations), Molecular Biology (1.3k citations), Infectious Diseases (387 citations), Virology (66 citations) and Oncology (197 citations). Ingmar Hoerr has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Hans‐Georg Rammensee, Steve Pascolo, Birgit Scheel, Günther Jung, Jochen Probst, Benjamin Weide, Reinhard Obst, Claus Garbe, Jean‐Philippe Carralot and Thomas Eigentler. Their work appears in journals such as European Journal of Immunology, Journal for ImmunoTherapy of Cancer, OncoImmunology, Journal of Immunotherapy and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.